查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390539

中风管理市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球卒中管理市场规模达到334亿美元。展望未来， IMARC Group预计到2028年市场规模将达到500亿美元，2022-2028年复合年增长率（CAGR）为6.96%。中风对医疗保健系统造成的负担不断增加，对以患者为中心的护理和个性化治疗计划的日益关注，以及为改善中风管理技术和开发新疗法而不断加大的研发力度，是推动市场发展的一些因素。

中风管理涉及一种综合方法来减少中风的影响和长期后果，中风是一种由大脑血流中断引起的医疗紧急情况。有效的中风管理对于最大限度地减少脑损伤、改善患者的治疗效果和提高生活品质至关重要。及时、准确的诊断对于中风治疗至关重要。快速评估工具，例如 FAST 缩写（脸部下垂、手臂无力、言语困难、呼叫紧急服务时间），有助于识别中风症状并及时进行医疗干预。诊断影像，例如电脑断层扫描 (CT) 扫描或磁振造影 (MRI)，有助于确定中风的类型和位置。立即治疗的重点是恢復大脑的血液流动。组织纤溶酶原激活剂 (tPA) 或机械血栓切除术等溶栓药物可用于治疗缺血性中风。出血性中风可能需要手术干预来止血并缓解大脑压力。中风后管理涉及復健以恢復丧失的功能并预防残疾。这可能包括物理治疗、职业治疗、语言治疗和心理支持。也可能会开立治疗高血压、高胆固醇和血液稀释剂等危险因子的药物。此外，预防措施对于降低中风復发的风险至关重要。生活方式的改变，例如健康饮食、定期运动、戒烟以及管理糖尿病或心房颤动等慢性疾病，对于中风管理至关重要。中风治疗和復健领域的持续研究和进步不断改善中风管理策略和结果。

全球市场主要是由中风发病率不断上升所推动的。与此一致的是，人口老化的加剧对市场做出了重大贡献。此外，诊断、影像和治疗选择方面不断进步的技术正在对市场产生积极影响。大众对中风症状和及时治疗重要性的认识不断提高，也刺激了市场。此外，政府针对中风预防和管理的运动和措施促进了市场扩张。此外，中风管理程序和治疗的优惠报销政策激励了医疗保健提供者并推动了市场。此外，远距医疗和远端监控技术的快速采用可以实现远端中风管理并扩大市场范围。专门的中风中心和专业设施的建立增强了中风管理能力并增强了市场。

中风管理市场趋势/驱动因素：

慢性病盛行率增加

慢性病盛行率的上升正在培育市场。心血管疾病、糖尿病和高血压等慢性疾病是主要的中风危险因子。随着全球人口老化和生活方式变得更加久坐，这些慢性病的盛行率持续增加。这导致更多的人面临中风的风险。慢性病盛行率的不断上升对有效的中风管理策略提出了更大的需求。敦促医疗保健提供者和组织制定全面的中风预防计划并实施及时有效的治疗方案。此外，越来越需要对慢性病进行持续监测和管理，以尽量减少中风发生或復发的风险。正在实施公共卫生措施、教育活动和预防措施，以提高人们对慢性病和中风之间关係的认识。这些努力旨在促进早期发现、生活方式改变和坚持治疗方案，最终减轻中风负担并推动中风管理解决方案市场的发展。

个人对早期诊断和治疗益处的认识不断提高

人们对早期诊断和治疗的好处的认识不断提高，为市场创造了积极的前景。随着大众对中风征兆、症状和后果的了解不断加深，人们越来越主动地寻求及时的医疗协助。意识的提高使个人能够及时识别中风症状并了解立即寻求医疗协助的重要性。识别出突然的麻木或虚弱、说话或理解困难以及严重头痛等症状会促使个人立即寻求紧急护理。早期诊断和及时治疗对于最大限度地减少中风的影响和改善患者的预后至关重要。随着意识的增强，个人更有可能迅​​速采取行动，从而更快地进行干预和可能挽救生命的治疗，例如溶栓药物或机械血栓切除术。提高意识的努力包括公共卫生运动、教育措施和社区外展计划。这些努力旨在教育个人有关中风预防、危险因素以及立即医疗干预的必要性。透过提高意识，个人能够采取积极主动的措施，提振中风管理解决方案市场并改善整体中风护理。

引进新的先进设备和药物

引进新的先进设备和药物为市场提供了许多机会。医疗设备和药品的技术进步和持续创新彻底改变了中风护理，改善了患者的治疗效果并促进了市场发展。先进影像、神经介入和机器人辅助系统等新设备提高了中风诊断和治疗的准确性和精确度。这些设备使医疗保健提供者能够快速有效地清除血栓，恢復大脑的血液流动，并最大限度地减少脑损伤的程度。此外，创新的復健设备和辅助技术有助于中风恢復和復原。新药和药物干预措施的发展也对推动市场发挥了至关重要的作用。溶栓药物、神经保护药物和抗血小板药物显着改善了中风的治疗和预防。这些药物旨在溶解血栓、保护脑细胞并控制危险因素，以降低中风復发的可能性。此外，新设备和药物的引入导致中风管理发生范式转变，实现更精确的诊断、微创治疗和标靶治疗。这些进步增强了患者护理，并为医疗保健提供者和製造商创造了新的机会，推动了市场的发展。

中风管理产业细分：

IMARC Group提供了全球卒中管理市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据类型、应用程式和最终用户对市场进行了分类。

按类型划分：

诊断

电脑断层扫描（CT 扫描）

磁振造影 (MRI)

颈动脉超音波检查

脑血管摄影

心电图

超音波心臟检查

其他的

疗法

组织纤溶酶原激活剂

抗凝血剂

抗血小板药

抗高血压

诊断主导市场

该报告根据类型提供了详细的市场细分和分析。这包括诊断（电脑断层扫描（CT 扫描）、磁振造影（MRI）、颈动脉超音波、脑血管摄影、心电图、超音波心动图等）和治疗（组织纤溶酶原激活剂、抗凝血剂、抗血小板剂和抗高血压剂）。根据该报告，诊断占据了最大的部分。

诊断对于准确识别和评估中风、做出及时有效的治疗决策至关重要。 CT 扫描和 MRI 是用于评估中风患者的关键诊断工具。 CT 扫描提供快速影像来检测血管出血或阻塞，帮助确定中风的类型和位置。另一方面，核磁共振成像可提供详细的脑部影像，有助于识别缺血区域并制定治疗计划。中风盛行率的增加以及对早期检测和介入的重视推动了对 CT 扫描和 MRI 等诊断工具的需求。

CT 和 MRI 影像的技术进步，例如更高的解析度、更快的扫描时间和改进的影像协议，提高了中风诊断的准确性和效率。将人工智慧 (AI) 演算法整合到成像系统中，实现成像资料的自动分析和解释，进一步推动了诊断领域的成长。这简化了诊断过程，加快了治疗决策，并改善了患者的治疗效果。

按应用划分：

缺血性中风

出血性中风

其他的

缺血性中风占最大市场份额

报告还提供了基于应用程式的详细市场细分和分析。这包括缺血性中风、出血性中风等。报告显示，缺血性中风占了最大的市场份额。

缺血性中风是最常见的类型，由供应大脑的血管阻塞或狭窄引起，导致血流量和氧气输送减少。对缺血性中风治疗的关注推动了市场的成长，因为它占中风病例的很大一部分。缺血性中风的发生率不断增加，通常与高血压、糖尿病和久坐生活方式等危险因子有关，需要有效的管理策略。

缺血性中风治疗的进步，例如组织纤溶酶原激活剂 (tPA) 等溶栓药物的开发和机械血栓切除术，彻底改变了治疗选择。这些干预措施旨在恢復受影响区域的血流，最大限度地减少脑损伤并改善患者的治疗结果。促进中风预防、早期识别症状和快速介入的公共卫生措施进一步支持了对缺血性中风管理的重视。这些措施透过提高意识、鼓励个人及时寻求医疗协助以及实施实证管理方法来推动市场发展。

按最终用户划分：

医院

门诊手术中心

诊断中心

其他的

医院占最大市场份额

报告还提供了基于最终用户的详细市场细分和分析。这包括医院、门诊手术中心、诊断中心等。报告显示，医院占据了最大的市场。

医院在中风治疗中发挥着至关重要的作用，因为它们是急性中风治疗、专业诊断和復健服务的主要医疗机构。医院需要为患者提供全面和专业的中风护理，这推动了对中风管理解决方案的需求。随着中风负担的增加，医院努力提高中风诊断、治疗和復原的能力，对市场产生正面影响。

医院投资先进的影像系统、神经介入设备和復健技术，以提供最佳的中风护理。他们与中风管理公司合作并参与临床研究，以实施实证实践并提供最新的治疗方案。此外，医院还充当中风教育和培训中心，向医疗保健专业人员传播有关中风预防、早期识别和适当管理的知识。这有助于改善患者的治疗效果并提高医疗保健界的认识，从而推动市场发展。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。

由于多种因素促进其成长和发展，北美是卒中管理的关键市场。该地区中风发病率很高，使其成为中风管理解决方案的重要市场。该地区人口老化、久坐的生活方式以及高血压和肥胖等危险因子的高发生率导致中风负担增加。此外，该地区拥有先进的医疗基础设施和强大的研发能力。这使得该地区能够在开发和采用创新的中风管理技术、诊断工具和治疗方式方面处于领先地位。

此外，北美拥有完善的医疗保健系统和报销结构，支援中风管理解决方案的采用。中风相关干预和治疗的优惠报销政策和保险范围推动了市场的发展。北美领先的中风管理公司、医疗保健提供者和研究机构的存在促进了中风管理实践的合作、研究和进步。这透过不断改善治疗效果并推动新技术和工艺的采用来促进市场成长。

竞争格局：

顶级中风管理公司正在透过其专业知识、创新和对改善患者治疗结果的承诺来加强市场。这些公司在研发方面投入巨资，开发尖端技术、设备和药品，以有效预防、诊断、治疗和復健中风。领先的中风管理公司积极与医疗保健提供者、研究机构和行业专家合作，推动创新并保持在中风护理领域的前沿。他们进行临床试验和研究以收集循证资料并不断改进其产品和服务。这些公司对于提高中风预防和早期介入的认识也至关重要。他们参与教育活动、公共卫生运动以及与患者倡导团体的合作，以提高中风意识并为医疗保健专业人员和公众提供资源。此外，顶级中风管理公司专注于提供涵盖诊断、急性护理、復健和持续管理的全面解决方案。透过提供以患者为中心的综合方法，他们致力于推动中风管理实践，努力优化患者治疗结果并提高生活品质。

该报告对中风管理市场的竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

雅培实验室

贝朗梅尔松根股份公司

波士顿科学公司

百时美施贵宝公司

康德乐

通用电气公司

葛兰素史克公司

美敦力公司

默克公司

西门子医疗保健公司（Siemens AG）。

最近的发展：

2019 年，雅培推出了 Alinity m 诊断系统，这是一个紧凑的分子检测平台，旨在为 HIV、肝炎等传染病提供快速、准确的结果。

2019 年，贝朗宣布与 GuardRFID Solutions 合作，增强公司的资产追踪和管理能力，并提高医疗保健环境的效率。

2019 年，波士顿科学公司的 WATCHMAN FLX 左心耳封堵器 (LAAC) 装置获得 FDA 批准，这是一种微创植入装置，用于降低非瓣膜性心房颤动患者中风的风险。

本报告回答的关键问题：

  • 迄今为止，全球卒中管理市场表现如何，未来几年将如何表现？
  • 全球卒中管理市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球卒中管理市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的中风管理市场？
  • 依类型划分市场是怎么样的？
  • 全球卒中管理市场中哪种类型最具吸引力？
  • 基于应用程式的市场区隔是什么？
  • 全球卒中管理市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 全球中风管理市场中哪一个是最具吸引力的最终用户？
  • 全球卒中管理市场的竞争结构如何？
  • 全球中风管理市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球卒中管理市场表现如何，未来几年将如何表现？
  • 全球卒中管理市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球卒中管理市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的中风管理市场？
  • 依类型划分市场是怎么样的？
  • 全球卒中管理市场中哪种类型最具吸引力？
  • 基于应用程式的市场区隔是什么？
  • 全球卒中管理市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 全球中风管理市场中哪一个是最具吸引力的最终用户？
  • 全球卒中管理市场的竞争结构如何？
  • 全球中风管理市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球中风管理市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按类型分類的市场细分

  • 诊断
    • 市场走向
    • 关键环节
      • 电脑断层扫描（CT 扫描）
      • 磁振造影 (MRI)
      • 颈动脉超音波检查
      • 脑血管摄影
      • 心电图
      • 超音波心臟检查
      • 其他的
    • 市场预测
  • 疗法
    • 市场走向
    • 关键环节
      • 组织纤溶酶原激活剂
      • 抗凝血剂
      • 抗血小板药
      • 抗高血压
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 缺血性中风
    • 市场走向
    • 市场预测
  • 出血性中风
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 诊断中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • Bristol-Myers Squibb Company
    • Cardinal Health
    • General Electric Company
    • GlaxoSmithKline plc
    • Medtronic plc
    • Merck & Co. Inc.
    • Siemens Healthineers AG (Siemens AG)
Product Code: SR112023A4313

Abstract

The global stroke management market size reached US$ 33.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 50.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.96% during 2022-2028. The rising burden of strokes on healthcare systems, the increasing focus on patient-centered care and personalized treatment plans, and the growing research and development efforts to improve stroke management techniques and develop new therapies are some of the factors propelling the market.

Stroke management involves a comprehensive approach to reduce the impact and long-term consequences of stroke, a medical emergency caused by disrupted blood flow to the brain. Effective stroke management is crucial to minimize brain damage, improve patient outcomes, and enhance quality of life. Prompt and accurate diagnosis is essential in stroke management. Quick assessment tools, such as the FAST acronym (Facial drooping, Arm weakness, Speech difficulties, Time to call emergency services), aid in identifying stroke symptoms and enabling timely medical intervention. Diagnostic imaging, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), helps determine the type and location of the stroke. Immediate treatment focuses on restoring blood flow to the brain. Clot-dissolving medications like tissue plasminogen activator (tPA) or mechanical thrombectomy may be used for ischemic stroke. Hemorrhagic stroke may require surgical interventions to stop bleeding and relieve pressure on the brain. Post-stroke management involves rehabilitation to restore lost functions and prevent disability. This may include physical therapy, occupational therapy, speech therapy, and psychological support. Medications to manage risk factors like high blood pressure, high cholesterol, and blood thinners may also be prescribed. Additionally, preventive measures are essential to reduce the risk of recurrent strokes. Lifestyle modifications such as a healthy diet, regular exercise, smoking cessation, and managing chronic conditions, such as diabetes or atrial fibrillation, are crucial to stroke management. Ongoing research and advancements in stroke treatment and rehabilitation continue to improve stroke management strategies and outcomes.

The global market is primarily driven by the growing incidence of strokes. In line with this, the increasing aging population is significantly contributing to the market. Furthermore, the rising technological advancements in diagnostics, imaging, and treatment options are positively influencing the market. The growing public awareness about the signs, symptoms, and importance of prompt stroke management is also catalyzing the market. Moreover, the government's campaigns and initiatives to address stroke prevention and management promote market expansion. Besides, the favorable reimbursement policies for stroke management procedures and treatments incentivize healthcare providers and propel the market. Additionally, the rapid adoption of telemedicine and remote monitoring technologies allows for remote stroke management and expands the market reach. The establishment of dedicated stroke centers and specialized facilities enhances stroke management capabilities and strengthens the market.

Stroke Management Market Trends/Drivers:

Increasing prevalence of chronic diseases

The rising prevalence of chronic diseases is fostering the market. Chronic diseases, such as cardiovascular diseases, diabetes, and hypertension, are major stroke risk factors. As the global population ages and lifestyles become more sedentary, the prevalence of these chronic conditions continues to increase. This results in a larger population at risk of experiencing strokes. The increasing prevalence of chronic diseases creates a greater demand for effective stroke management strategies. Healthcare providers and organizations are prompted to develop comprehensive stroke prevention programs and implement timely and efficient treatment protocols. Additionally, there is a growing need for ongoing monitoring and management of chronic conditions to minimize the risk of stroke occurrence or recurrence. Public health initiatives, education campaigns, and preventive measures are being implemented to raise awareness about the relationship between chronic diseases and strokes. These efforts aim to promote early detection, lifestyle modifications, and adherence to treatment regimens, ultimately reducing the burden of strokes and fueling the market for stroke management solutions.

Rising awareness among individuals regarding the benefits of early diagnosis and treatments

Rising awareness among individuals about the benefits of early diagnosis and treatments is creating a positive outlook for the market. As public knowledge about the signs, symptoms, and consequences of strokes improves, individuals are becoming more proactive in seeking timely medical attention. Increased awareness empowers individuals to recognize stroke symptoms promptly and understand the importance of seeking immediate medical help. Recognizing symptoms such as sudden numbness or weakness, difficulty speaking or understanding, and severe headache prompts individuals to seek emergency care without delay. Early diagnosis and prompt treatment are critical in minimizing the impact of strokes and improving patient outcomes. With greater awareness, individuals are more likely to act swiftly, leading to faster intervention and potentially life-saving treatments such as clot-dissolving medications or mechanical thrombectomy. Efforts to raise awareness include public health campaigns, educational initiatives, and community outreach programs. These endeavors aim to educate individuals about stroke prevention, risk factors, and the need for immediate medical intervention. By increasing awareness, individuals are empowered to take proactive measures, bolstering the market for stroke management solutions and improving overall stroke care.

Introduction of new and advanced devices and drugs

Introducing new and advanced devices and drugs offers numerous opportunities for the market. Technological advancements and continuous innovation in medical devices and pharmaceuticals have revolutionized stroke care, improving patient outcomes and catalyzing the market. New devices, such as advanced imaging, neuro-interventional, and robotic-assisted systems, have enhanced the accuracy and precision of stroke diagnosis and treatment. These devices enable healthcare providers to swiftly and effectively remove clots, restore blood flow to the brain, and minimize the extent of brain damage. Additionally, innovative rehabilitation devices and assistive technologies aid in stroke recovery and rehabilitation. The development of new drugs and pharmaceutical interventions has also played a vital role in driving the market. Thrombolytic drugs, neuroprotective agents, and antiplatelet medications have significantly improved stroke treatment and prevention. These drugs aim to dissolve clots, protect brain cells, and manage risk factors to reduce the likelihood of recurrent strokes. Moreover, introducing new devices and drugs has led to a paradigm shift in stroke management, enabling more precise diagnoses, minimally invasive treatments, and targeted therapies. These advancements enhance patient care and create new opportunities for healthcare providers and manufacturers, propelling the market.

Stroke Management Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global stroke management market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Diagnostics

Computed Tomography Scan (CT Scan)

Magnetic Resonance Imaging (MRI)

Carotid Ultrasound

Cerebral Angiography

Electrocardiography

Echocardiography

Others

Therapeutics

Tissue Plasminogen Activator

Anticoagulant

Antiplatelet

Antihypertensive

Diagnostics dominate the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes diagnostics (computed tomography scan (CT Scan), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, others) and therapeutics (tissue plasminogen activator, anticoagulant, antiplatelet, and antihypertensive). According to the report, diagnostics represented the largest segment.

Diagnostics are crucial in accurately identifying and assessing strokes, enabling timely and effective treatment decisions. CT scans and MRIs are key diagnostic tools used to evaluate stroke patients. CT scans provide rapid imaging to detect bleeding or blockages in blood vessels, helping determine the type and location of the stroke. MRIs, on the other hand, offer detailed brain imaging, assisting in identifying ischemic areas and aiding in treatment planning. The increasing prevalence of strokes and the emphasis on early detection and intervention drive the demand for diagnostic tools, such as CT scans and MRIs.

Technological advancements in CT and MRI imaging, such as higher resolution, faster scanning times, and improved imaging protocols, have enhanced the accuracy and efficiency of stroke diagnosis. The diagnostics segment's growth is further fuelled by integrating artificial intelligence (AI) algorithms into imaging systems, enabling automated analysis and interpretation of imaging data. This streamlines the diagnostic process, expedites treatment decisions, and improves patient outcomes.

Breakup by Application:

Ischemic Stroke

Haemorrhagic Stroke

Others

Ischemic Stroke holds the largest share of the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes ischemic stroke, haemorrhagic stroke, and others. According to the report, ischemic stroke accounted for the largest market share.

Ischemic stroke is the most common type, caused by the blockage or narrowing of blood vessels supplying the brain, leading to reduced blood flow and oxygen delivery. The focus on ischemic stroke management drives themarket growth as it accounts for a substantial portion of stroke cases. The increasing incidence of ischemic stroke, often associated with risk factors like hypertension, diabetes, and a sedentary lifestyle, demands effective management strategies.

Advancements in ischemic stroke management, such as the development of thrombolytic drugs like tissue plasminogen activator (tPA) and mechanical thrombectomy procedures, have revolutionized treatment options. These interventions aim to restore blood flow to the affected area, minimize brain damage, and improve patient outcomes. The emphasis on ischemic stroke management is further supported by public health initiatives promoting stroke prevention, early recognition of symptoms, and rapid intervention. These initiatives propel the market by increasing awareness, encouraging individuals to seek medical help promptly, and implementing evidence-based management approaches.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Diagnostic Centers

Others

Hospitals holds the largest share of the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, ambulatory surgical centers, diagnostic centers, and others. According to the report, hospitals accounted for the largest market share.

Hospitals play a critical role in stroke care, as they are the primary healthcare facilities for acute stroke treatment, specialized diagnostics, and rehabilitation services. The demand for stroke management solutions is propelled by hospitals' need to provide patients with comprehensive and specialized stroke care. As the burden of strokes rises, hospitals strive to enhance their capabilities in stroke diagnosis, treatment, and rehabilitation, impacting the market positively.

Hospitals invest in advanced imaging systems, neuro-interventional devices, and rehabilitation technologies to deliver optimal stroke care. They collaborate with stroke management companies and engage in clinical research to implement evidence-based practices and offer the latest treatment options. Furthermore, hospitals serve as centers for stroke education and training, disseminating knowledge to healthcare professionals regarding stroke prevention, early recognition, and appropriate management. This contributes to improved patient outcomes and raises awareness among the healthcare community, propelling the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

North America is a key market for stroke management due to several factors contributing to its growth and development. The region has a high prevalence of stroke cases, making it a significant market for stroke management solutions. The region's aging population, sedentary lifestyles, and high incidence of risk factors such as hypertension and obesity contribute to the increased burden of strokes. Furthermore, the region boasts advanced healthcare infrastructure and robust research and development capabilities. This enables the region to lead in developing and adopting innovative stroke management technologies, diagnostic tools, and treatment modalities.

Moreover, North America has a well-established healthcare system and reimbursement structure that supports the adoption of stroke management solutions. Favorable reimbursement policies and insurance coverage for stroke-related interventions and treatments drive the market. The presence of leading stroke management companies, healthcare providers, and research institutions in North America fosters collaboration, research, and advancements in stroke management practices. This contributes to the market growth by continually improving treatment outcomes and driving the adoption of new technologies and techniques.

Competitive Landscape:

Top stroke management companies are strengthening the market through their expertise, innovation, and commitment to improving patient outcomes. These companies invest heavily in research and development to develop cutting-edge technologies, devices, and pharmaceuticals for effective stroke prevention, diagnosis, treatment, and rehabilitation. Leading stroke management companies actively collaborate with healthcare providers, research institutions, and industry experts to drive innovation and stay at the forefront of stroke care. They conduct clinical trials and studies to gather evidence-based data and continuously improve their products and services. These companies are also crucial in raising awareness about stroke prevention and early intervention. They engage in educational initiatives, public health campaigns, and partnerships with patient advocacy groups to promote stroke awareness and provide resources to healthcare professionals and the general public. Moreover, top stroke management companies focus on delivering comprehensive solutions that encompass diagnostics, acute care, rehabilitation, and ongoing management. By offering integrated and patient-centric approaches, they strive to optimize patient outcomes and improve quality of life through their commitment to advancing stroke management practices.

The report has provided a comprehensive analysis of the competitive landscape in the stroke management market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

B. Braun Melsungen AG

Boston Scientific Corporation

Bristol-Myers Squibb Company

Cardinal Health

General Electric Company

GlaxoSmithKline plc

Medtronic plc

Merck & Co. Inc.

Siemens Healthineers AG (Siemens AG).

Recent Developments:

In 2019, Abbott launched the Alinity m diagnostics system, a compact molecular testing platform designed to deliver fast and accurate results for infectious diseases like HIV, hepatitis, and more.

In 2019, B. Braun announced a collaboration with GuardRFID Solutions to enhance the company's asset tracking and management capabilities, improving efficiency in healthcare environments.

In 2019, Boston Scientific received FDA approval for the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device, a minimally invasive implantable device for reducing the risk of stroke in patients with non-valvular atrial fibrillation.

Key Questions Answered in This Report:

  • How has the global stroke management market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global stroke management market?
  • What is the impact of each driver, restraint, and opportunity on the global stroke management market?
  • What are the key regional markets?
  • Which countries represent the most attractive stroke management market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the global stroke management market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the global stroke management market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global stroke management market?
  • What is the competitive structure of the global stroke management market?
  • Who are the key players/companies in the global stroke management market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stroke Management Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostics
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Computed Tomography Scan (CT Scan)
      • 6.1.2.2 Magnetic Resonance Imaging (MRI)
      • 6.1.2.3 Carotid Ultrasound
      • 6.1.2.4 Cerebral Angiography
      • 6.1.2.5 Electrocardiography
      • 6.1.2.6 Echocardiography
      • 6.1.2.7 Others
    • 6.1.3 Market Forecast
  • 6.2 Therapeutics
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Tissue Plasminogen Activator
      • 6.2.2.2 Anticoagulant
      • 6.2.2.3 Antiplatelet
      • 6.2.2.4 Antihypertensive
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Ischemic Stroke
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Haemorrhagic Stroke
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cardinal Health
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 GlaxoSmithKline plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Merck & Co. Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens Healthineers AG (Siemens AG)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Stroke Management Market: Major Drivers and Challenges
  • Figure 2: Global: Stroke Management Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Stroke Management Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Stroke Management Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Stroke Management Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Stroke Management Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Stroke Management Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Stroke Management (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Stroke Management (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Stroke Management (Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Stroke Management (Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Stroke Management (Ischemic Stroke) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Stroke Management (Ischemic Stroke) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Stroke Management (Haemorrhagic Stroke) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Stroke Management (Haemorrhagic Stroke) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Stroke Management (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Stroke Management (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Stroke Management (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Stroke Management (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Stroke Management (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Stroke Management (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Stroke Management (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Stroke Management (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Stroke Management (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Stroke Management (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Stroke Management Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Stroke Management Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Stroke Management Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Stroke Management Industry: SWOT Analysis
  • Figure 76: Global: Stroke Management Industry: Value Chain Analysis
  • Figure 77: Global: Stroke Management Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Stroke Management Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Stroke Management Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Stroke Management Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Stroke Management Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Stroke Management Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Stroke Management Market: Competitive Structure
  • Table 7: Global: Stroke Management Market: Key Players